ATE309820T1 - Verwendung einer parathyroidhormone zur reduktion des krebsrisikos - Google Patents

Verwendung einer parathyroidhormone zur reduktion des krebsrisikos

Info

Publication number
ATE309820T1
ATE309820T1 AT00961714T AT00961714T ATE309820T1 AT E309820 T1 ATE309820 T1 AT E309820T1 AT 00961714 T AT00961714 T AT 00961714T AT 00961714 T AT00961714 T AT 00961714T AT E309820 T1 ATE309820 T1 AT E309820T1
Authority
AT
Austria
Prior art keywords
cancer
risk
reduce
parathyroid hormones
parathyroid
Prior art date
Application number
AT00961714T
Other languages
English (en)
Inventor
Janet M Hock
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE309820T1 publication Critical patent/ATE309820T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00961714T 1999-09-20 2000-09-11 Verwendung einer parathyroidhormone zur reduktion des krebsrisikos ATE309820T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15545599P 1999-09-20 1999-09-20
PCT/US2000/024746 WO2001021198A1 (en) 1999-09-20 2000-09-11 Method for reducing the risk of cancer

Publications (1)

Publication Number Publication Date
ATE309820T1 true ATE309820T1 (de) 2005-12-15

Family

ID=22555504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00961714T ATE309820T1 (de) 1999-09-20 2000-09-11 Verwendung einer parathyroidhormone zur reduktion des krebsrisikos

Country Status (11)

Country Link
US (1) US20050192227A1 (de)
EP (1) EP1221966B1 (de)
AR (1) AR025718A1 (de)
AT (1) ATE309820T1 (de)
AU (1) AU7363000A (de)
CA (1) CA2383574A1 (de)
DE (1) DE60024118T2 (de)
ES (1) ES2250187T3 (de)
PE (1) PE20010666A1 (de)
SV (1) SV2002000179A (de)
WO (1) WO2001021198A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022093A1 (en) * 1999-09-20 2001-03-29 Eli Lilly And Company Method for monitoring treatment with a parathyroid hormone
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
HUE038395T2 (hu) 2003-11-20 2018-10-29 Novo Nordisk As Propilén-glikol tartalmú peptidkészítmények, amelyek elõállításra és injekciós eszközökben történõ alkalmazásra optimálisak
EP1557176A1 (de) * 2004-01-26 2005-07-27 Ferring B.V. Behandlung von Knochen-Metastasen mit Hilfe von PTH-Rezeptor-Agonisten
MXPA06013168A (es) 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
US20090042774A1 (en) * 2005-09-06 2009-02-12 Paul Morley Parathyroid hormone analogues and methods of use
CN101355959B (zh) * 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
EP2509996A1 (de) 2009-12-07 2012-10-17 Michigan Technological University Schwarzbär-parathyroid-hormon und verfahren zur verwendung des schwarzbär-parathyroid-hormons
KR20150116467A (ko) * 2011-06-07 2015-10-15 아사히 가세이 파마 가부시키가이샤 고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
CA3082033A1 (en) 2017-08-24 2019-02-28 Novo Nordisk A\S Glp-1 compositions and uses thereof
PE20230819A1 (es) 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US5527772A (en) * 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
US5608108A (en) * 1988-11-14 1997-03-04 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and method of use thereof
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
WO1997027870A1 (fr) * 1996-02-01 1997-08-07 Chugai Seiyaku Kabushiki Kaisha Medicaments prevenant ou guerissant la thrombopenie
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof

Also Published As

Publication number Publication date
ES2250187T3 (es) 2006-04-16
US20050192227A1 (en) 2005-09-01
EP1221966B1 (de) 2005-11-16
AR025718A1 (es) 2002-12-11
AU7363000A (en) 2001-04-24
SV2002000179A (es) 2002-07-16
PE20010666A1 (es) 2001-06-20
WO2001021198A1 (en) 2001-03-29
DE60024118T2 (de) 2006-07-27
CA2383574A1 (en) 2001-03-29
EP1221966A1 (de) 2002-07-17
DE60024118D1 (de) 2005-12-22

Similar Documents

Publication Publication Date Title
DE60001709D1 (de) Möglichkeit zur Korrektur des Strahlungsdiagramms einer linearen Antenne
DE60042550D1 (de) Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
EP1323034A4 (de) Gemeinsames anwendungs-metamodell mit einem metamodell in c/c++
FI20002882A0 (fi) Järjestely antennin sovittamiseksi
DK1175408T3 (da) Pyrimidinonforbindelser
DE69935075D1 (de) Biegsames transmyokardimplantat zur induktion der angiogenese
DE69933937D1 (de) Biegsames transmyokardimplantat zur induktion der angiogenese
DE50015401D1 (de) Gitter zur Absorption von Röntgenstrahlung
AU148333S (en) Adhesive bandage
DE50015405D1 (de) Gitter zur Absorption von Röntgenstrahlen
GB2378791B (en) Branch locking of job tickets to control concurrency
ATE309820T1 (de) Verwendung einer parathyroidhormone zur reduktion des krebsrisikos
GB0110817D0 (en) Bandage applicator
DE60234341D1 (de) Chinazoline derivative zur förderung der freisetzung von parathyroidmshormonen
DE60044925D1 (de) Die Verwendung einer Riechstoffzusammensetzung enthaltend Anisaldehyd
DE60038225D1 (de) Oberflächenmodifizierer
DE59909904D1 (de) Umhängenadel zur Maschenübertragung
DE69917794D1 (de) Kontinuierliche mischanlage
NO20013257D0 (no) Ben stimulerende faktor
DE69917166D1 (de) Wärmehärtendes Klebemittel
DE60220516D1 (de) Aromatase hemmung zur steigerung der implantationsrate
GB0009631D0 (en) Adhesive applicator
ATE294812T1 (de) 16alpha-methyl oder ethyl substituierte oestrogene
FR2798221B1 (fr) Transformateur de rayonnement
DE29903131U1 (de) Implantat zur Festlegung einer Knochenplatte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties